期刊文献+

EBV-AHS患儿血清LMP1、炎症因子的表达及诊断价值

下载PDF
导出
摘要 目的分析EB病毒相关性噬血细胞综合征(EBV-AHS)患儿血清EB病毒潜伏膜蛋1(LMP1)、肿瘤坏死因子-α(TNF-α)、干扰素-γ(IFN-γ)、白介素-2(IL-2)变化及其对疾病的诊断价值。方法选取2018年2月~2019年11月我院收治的102例EBV-AHS患儿纳入EBV-AHS组,另选取同期于我院体检的50例健康儿童作为对照组,分析两组血清指标差异。结果EBV-AHS组血清LMP1抗体A值与TNF-α、IFN-γ、IL-2水平高于对照组(P<0.05);Pearson相关性分析EBV-AHS患儿血清LMP1抗体A值与血清TNF-α、IFN-γ、IL-2水平呈显著正相关(r=0.602、0.534、0.501,P<0.05);ROC曲线结果提示,联合血清LMP1抗体A值与TNF-α、IFN-γ、IL-2值诊断EBV-AHS的曲线下面积(AUC)为0.960大于单一诊断的0.857、0.842、0.865、0.841(P<0.05)。结论EBV-AHS患儿血清LMP1、TNF-α、IFN-γ、IL-2水平均较健康儿童明显升高,联合血清LMP1、TNF-α、IFN-γ、IL-2可提高EBV-AHS的临床诊断价值。
作者 钱行
出处 《现代诊断与治疗》 CAS 2021年第21期3488-3490,共3页 Modern Diagnosis and Treatment
  • 相关文献

参考文献5

二级参考文献67

  • 1Teachey DT, Rheingold SR, Maude SL, et al. Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy [J]. Blood, 2013,121(26) :5154-5157.
  • 2Grupp SA, Kalos M, Barrett D, et al. Chimeric antigen recep- tor-modified T cells for acute lymphoid leukemia [J]. The New England journal of medicine,2013,368(16) :1509-1518.
  • 3Ramos-Casals M, Brito-Zeron P, Lopez-Guillermo A, et al. A- dult haemophagocytic syndrome [J]. Lancet, 2014,383 (9927) : 1503-1516.
  • 4Davi S, Consolaro A, Guseinova D, et al. An international con- sensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis [J]. The Jour- nal of rheumatology, 2011,38(4) :764-768.
  • 5Grom AA, Mellins ED. Macrophage activation syndrome., ad- vances towards understanding pathogenesis [J]. Current opinion in rheumatology, 2010,22 (5) : 561-566.
  • 6Bleesing J, Prada A, Siegel DM, et al. The diagnostic signifi- cance of soluble CD163 and soluble interleukin-2 receptor alpha- chain in macrophage activation syndrome and untreated new-on- set systemic juvenile idiopathic arthritis [J]. Arthritis and rheu- matism, 2007,56(3) :965-971.
  • 7Behrens EM, Canna SW, Slade K, et al. Repeated TLR9 stim- ulation results in macrophage activation syndrome-like disease in mice [J]. The Journal of clinical investigation, 2011,121 (6) : 2264-2277.
  • 8Jordan MB, Allen CE, Weitzman S, et al. How I treat hemophago- eyrie lymphohistiocytosis [J]. Blood,2011,118(15):4041-4052.
  • 9Chandrakasan S, Filipovich AH. Hemophagocytic lymphohistio- cytosis: advances in pathophysiology, diagnosis, and treatment [J]. The Journal of pediatrics, 2013,163(5):1253-1259.
  • 10Janka GE, Lehmberg K. Hemophagocytic syndromes--an update [J]. Blood reviews, 2014,28(4) :135-142.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部